Finally, since MAFB-dependent factors like IL-10, SPP1, CCL2, and CXCL13 are biomarkers for COVID-19 severity (63, 65–71, 74, 75), we next assessed whether additional MAFB-dependent soluble factors might also predict COVID-19 severity or outcome. The gene discussed is CCL2; the disease is COVID-19.